\BOOKMARK [0][-]{chapter.1}{Introduction}{}% 1
\BOOKMARK [0][-]{chapter.2}{Physical Principles}{}% 2
\BOOKMARK [1][-]{section.2.1}{Energy loss of photons in matter}{chapter.2}% 3
\BOOKMARK [2][-]{subsection.2.1.1}{Photoelectric effect}{section.2.1}% 4
\BOOKMARK [2][-]{subsection.2.1.2}{Compton scattering}{section.2.1}% 5
\BOOKMARK [2][-]{subsection.2.1.3}{Pair production}{section.2.1}% 6
\BOOKMARK [2][-]{subsection.2.1.4}{Combined cross section for photons in matter}{section.2.1}% 7
\BOOKMARK [2][-]{subsection.2.1.5}{Interaction of Charged Particles with Matter}{section.2.1}% 8
\BOOKMARK [1][-]{section.2.2}{Radiation biology of photons}{chapter.2}% 9
\BOOKMARK [2][-]{subsection.2.2.1}{DNA radiation damage}{section.2.2}% 10
\BOOKMARK [2][-]{subsection.2.2.2}{The linear-quadratic model}{section.2.2}% 11
\BOOKMARK [2][-]{subsection.2.2.3}{Oxygen effect}{section.2.2}% 12
\BOOKMARK [2][-]{subsection.2.2.4}{Origin of hypoxia in tumours}{section.2.2}% 13
\BOOKMARK [2][-]{subsection.2.2.5}{Impact of hypoxia on cell survival}{section.2.2}% 14
\BOOKMARK [2][-]{subsection.2.2.6}{Assessment of chronic and acute hypoxia}{section.2.2}% 15
\BOOKMARK [1][-]{section.2.3}{Treatment planning}{chapter.2}% 16
\BOOKMARK [2][-]{subsection.2.3.1}{Dose delivery with IMRT}{section.2.3}% 17
\BOOKMARK [2][-]{subsection.2.3.2}{Treament planning with KonRad}{section.2.3}% 18
\BOOKMARK [2][-]{subsection.2.3.3}{Physical Objective function}{section.2.3}% 19
\BOOKMARK [2][-]{subsection.2.3.4}{Dose calculation \046 biological effect}{section.2.3}% 20
\BOOKMARK [2][-]{subsection.2.3.5}{Biological objective function}{section.2.3}% 21
\BOOKMARK [0][-]{chapter.3}{Dose Painting Based on PET Images}{}% 22
\BOOKMARK [1][-]{section.3.1}{PET Imaging}{chapter.3}% 23
\BOOKMARK [2][-]{subsection.3.1.1}{ decay}{section.3.1}% 24
\BOOKMARK [2][-]{subsection.3.1.2}{Physical principle of PET}{section.3.1}% 25
\BOOKMARK [1][-]{section.3.2}{Quantification of hypoxia}{chapter.3}% 26
\BOOKMARK [2][-]{subsection.3.2.1}{Radiopharmaceutical approach to hypoxia assessment}{section.3.2}% 27
\BOOKMARK [2][-]{subsection.3.2.2}{Modelling hypoxia with FMISO}{section.3.2}% 28
\BOOKMARK [2][-]{subsection.3.2.3}{Correlation of tumour hypoxia vs. FMISO uptake values}{section.3.2}% 29
\BOOKMARK [2][-]{subsection.3.2.4}{Eppendorf polarographic needle electrodes}{section.3.2}% 30
\BOOKMARK [1][-]{section.3.3}{Review of dose painting methods}{chapter.3}% 31
\BOOKMARK [2][-]{subsection.3.3.1}{Binary dose escalation}{section.3.3}% 32
\BOOKMARK [2][-]{subsection.3.3.2}{Functional dose escalation}{section.3.3}% 33
\BOOKMARK [2][-]{subsection.3.3.3}{Dose painting by numbers via kinetic models}{section.3.3}% 34
\BOOKMARK [2][-]{subsection.3.3.4}{MRI dose painting}{section.3.3}% 35
\BOOKMARK [1][-]{section.3.4}{Novel approach: biological dose painting}{chapter.3}% 36
\BOOKMARK [2][-]{subsection.3.4.1}{Implementation of biological dose painting in KonRad}{section.3.4}% 37
\BOOKMARK [2][-]{subsection.3.4.2}{Clinical tumour hypoxia}{section.3.4}% 38
\BOOKMARK [2][-]{subsection.3.4.3}{PET imaging}{section.3.4}% 39
\BOOKMARK [1][-]{section.3.5}{Implementation of biological dose painting}{chapter.3}% 40
\BOOKMARK [2][-]{subsection.3.5.1}{Creation of realistic artificial PET images}{section.3.5}% 41
\BOOKMARK [2][-]{subsection.3.5.2}{Plan comparison}{section.3.5}% 42
\BOOKMARK [0][-]{chapter.4}{Feasibility of Biological Dose Painting}{}% 43
\BOOKMARK [1][-]{section.4.1}{Patients}{chapter.4}% 44
\BOOKMARK [1][-]{section.4.2}{Application of biological dose painting}{chapter.4}% 45
\BOOKMARK [1][-]{section.4.3}{Results}{chapter.4}% 46
\BOOKMARK [2][-]{subsection.4.3.1}{Impact of modelling}{section.4.3}% 47
\BOOKMARK [2][-]{subsection.4.3.2}{Delivery quality and feasibility of dose painting}{section.4.3}% 48
\BOOKMARK [2][-]{subsection.4.3.3}{Nominal plan vs biological dose painting}{section.4.3}% 49
\BOOKMARK [1][-]{section.4.4}{Discussion}{chapter.4}% 50
\BOOKMARK [2][-]{subsection.4.4.1}{Feasibility of biological dose painting}{section.4.4}% 51
\BOOKMARK [2][-]{subsection.4.4.2}{High dose fractions}{section.4.4}% 52
\BOOKMARK [2][-]{subsection.4.4.3}{Size of hypoxic volumes}{section.4.4}% 53
\BOOKMARK [1][-]{section.4.5}{Conclusion}{chapter.4}% 54
\BOOKMARK [0][-]{chapter.5}{Efficacy of Biological Dose Painting}{}% 55
\BOOKMARK [1][-]{section.5.1}{Model parameter uncertainties}{chapter.5}% 56
\BOOKMARK [2][-]{subsection.5.1.1}{pO2 model}{section.5.1}% 57
\BOOKMARK [2][-]{subsection.5.1.2}{Hypoxia reduction factors}{section.5.1}% 58
\BOOKMARK [1][-]{section.5.2}{Results}{chapter.5}% 59
\BOOKMARK [1][-]{section.5.3}{Discussion}{chapter.5}% 60
\BOOKMARK [1][-]{section.5.4}{Conclusion}{chapter.5}% 61
\BOOKMARK [0][-]{chapter.6}{Outlook: Improving Biological Dose Painting}{}% 62
\BOOKMARK [1][-]{section.6.1}{Understanding PET images}{chapter.6}% 63
\BOOKMARK [2][-]{subsection.6.1.1}{Accuracy of PET images}{section.6.1}% 64
\BOOKMARK [2][-]{subsection.6.1.2}{Temporal variance}{section.6.1}% 65
\BOOKMARK [2][-]{subsection.6.1.3}{Reoxygenation \046 single image planning}{section.6.1}% 66
\BOOKMARK [1][-]{section.6.2}{Interpretation of hypoxia}{chapter.6}% 67
\BOOKMARK [0][-]{chapter.7}{Summary \046 Conclusions}{}% 68
\BOOKMARK [0][-]{appendix.A}{Dose compensation for hypoxia}{}% 69
\BOOKMARK [0][-]{appendix.B}{Patient statistics}{}% 70
\BOOKMARK [0][-]{section*.41}{Bibliography}{}% 71
